These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3207258)

  • 1. Thymopoietin: a marker of the human nicotinic acetylcholine receptor.
    Morel E; Vernet-der-Garabedian B; Raimond F; Audhya TK; Goldstein G; Bach JF
    Ann N Y Acad Sci; 1988; 540():298-300. PubMed ID: 3207258
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of thymopoietin to the acetylcholine receptor.
    Venkatasubramanian K; Audhya T; Goldstein G
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3171-4. PubMed ID: 3458173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for thymopoietin and thymopoietin/alpha-bungarotoxin/nicotinic receptors within the brain.
    Quik M; Babu U; Audhya T; Goldstein G
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2603-7. PubMed ID: 1848710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperativity of thymopoietin 32-36 (the active site) and thymopoietin 38-45 in receptor binding.
    Audhya T; Heavner GA; Kroon DJ; Goldstein G
    Regul Pept; 1984 Oct; 9(3):155-64. PubMed ID: 6098937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymopoietin, a thymic polypeptide, potently interacts at muscle and neuronal nicotinic alpha-bungarotoxin receptors.
    Quik M
    Mol Neurobiol; 1992; 6(1):19-40. PubMed ID: 1463587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymopoietin-like substance in human skin.
    Chu AC; Goldstein G; Patterson J; Berger C; Takezaki S; Edelson R
    Lancet; 1982 Oct; 2(8301):766-7. PubMed ID: 6125832
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymopoietin, a thymic polypeptide, regulates nicotinic alpha-bungarotoxin sites in chromaffin cells in culture.
    Quik M; Afar R; Geertsen S; Audhya T; Goldstein G; Trifaró JM
    Mol Pharmacol; 1990 Jan; 37(1):90-7. PubMed ID: 1967819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thymus hormones: chemical characteristics and biological properties].
    Astaldi A
    Pathologica; 1976; 68(975-976):1-8. PubMed ID: 1012782
    [No Abstract]   [Full Text] [Related]  

  • 9. Myasthenic sera recognize the human acetylcholine receptor bound to thymopoietin.
    Morel E; Vernet-der Garabedian B; Raimond F; Audhya TK; Goldstein G; Bach JF
    Eur J Immunol; 1987 Aug; 17(8):1109-13. PubMed ID: 3622601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junction.
    Quik M; Collier B; Audhya T; Goldstein G
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1113-9. PubMed ID: 1967127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide analogs of thymopentin distinguish distinct thymopoietin receptor specificities on two human T cell lines.
    Heavner GA; Audhya T; Goldstein G
    Regul Pept; 1990 Feb; 27(2):257-62. PubMed ID: 2158125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin.
    Goldstein G; Schlesinger DH
    Lancet; 1975 Aug; 2(7928):256-9. PubMed ID: 49801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in the research on immunopathogenesis of myasthenia gravis].
    Zieliński M; Kuzdzał J; Soja J; Szlubowski A
    Neurol Neurochir Pol; 2003; 37(5):1085-94. PubMed ID: 15174254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The isolation of thymopoietin (thymin).
    Goldstein G
    Ann N Y Acad Sci; 1975 Feb; 249():177-85. PubMed ID: 165765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioassay determinations of thymopoietin and thymic hormone levels in human plasma.
    Twomey JJ; Goldstein G; Lewis VM; Bealmear PM; Good RA
    Proc Natl Acad Sci U S A; 1977 Jun; 74(6):2541-5. PubMed ID: 302007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of thymopoietin peptides with the specific receptor of facteur thymique serique (FTS).
    Gastinel LN; Pleau JM; Goldstein G; Bach JF
    Thymus; 1983 Mar; 5(2):78-87. PubMed ID: 6304947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell cultures.
    Quik M; el-Bizri H; Audhya T; Goldstein G
    Mol Pharmacol; 1991 Mar; 39(3):324-31. PubMed ID: 2005877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymic hormone-containing cells VI. Immunohistologic evidence for the simultaneous presence of thymulin, thymopoietin and thymosin alpha 1 in normal and pathological human thymuses.
    Savino W; Dardenne M
    Eur J Immunol; 1984 Nov; 14(11):987-91. PubMed ID: 6389155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thymus and myasthenia gravis: immunological and neurophysiological aspects.
    Carrieri PB; Marano E; Perretti A; Caruso G
    Ann Med; 1999 Oct; 31 Suppl 2():52-6. PubMed ID: 10574156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating thymic-hormone activity in congenital immunodeficiency.
    Lewis V; Twomey JJ; Goldstein G; O'Reilly R; Smithwick E; Pahwa R; Pahwa S; Good RA; Schulte-Wisserman H; Horowitz S; Hong R; Jones J; Sieber O; Kirkpatrick C; Polmar S; Bealmear P
    Lancet; 1977 Sep; 2(8036):471-5. PubMed ID: 70687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.